Obsessive-compulsive disorder: a double-blind, placebo-controlled trial of clomipramine in 27 patients

M A Jenike; L Baer; P Summergrad; J B Weilburg; A Holland; R Seymour

doi:10.1176/ajp.146.10.1328

Obsessive-compulsive disorder: a double-blind, placebo-controlled trial of clomipramine in 27 patients

Am J Psychiatry. 1989 Oct;146(10):1328-30. doi: 10.1176/ajp.146.10.1328.

Authors

M A Jenike¹, L Baer, P Summergrad, J B Weilburg, A Holland, R Seymour

Affiliation

¹ Harvard Medical School and Massachusetts General Hospital, Boston 02114.

PMID: 2675643
DOI: 10.1176/ajp.146.10.1328

Abstract

Clomipramine was significantly superior to placebo in a 10-week double-blind, placebo-controlled trial in 27 outpatients who met DSM-III-R criteria for obsessive-compulsive disorder.

Publication types

Clinical Trial
Controlled Clinical Trial
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Ambulatory Care
Clinical Trials as Topic
Clomipramine / therapeutic use*
Double-Blind Method
Female
Humans
Male
Obsessive-Compulsive Disorder / drug therapy*
Obsessive-Compulsive Disorder / psychology
Placebos
Psychiatric Status Rating Scales

Substances

Placebos
Clomipramine